{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:55:14Z","timestamp":1791158114709,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":964,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.seizure.2010.10.011","type":"journal-article","created":{"date-parts":[[2010,11,20]],"date-time":"2010-11-20T04:36:18Z","timestamp":1290227778000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy"],"prefix":"10.1016","volume":"20","author":[{"given":"S.","family":"Dedeurwaerdere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"van Raay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2010.10.011_bib0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2010.10.011_bib0010","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2010.10.011_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0987-7053(88)80104-7","article-title":"Treatment of status epilepticus by sodium valproate","volume":"18","author":"Giroud","year":"1988","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.seizure.2010.10.011_bib0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2165\/00003495-199447020-00008","article-title":"Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.seizure.2010.10.011_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0447.2005.00522.x","article-title":"Valproate in bipolar disorder: 2000 onwards","author":"Bowden","year":"2005","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.seizure.2010.10.011_bib0030","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1289\/txg.7034","article-title":"Valproic acid teratogenicity: a toxicogenomics approach","volume":"112","author":"Kultima","year":"2004","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.seizure.2010.10.011_bib0035","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jocn.2004.05.003","article-title":"Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy","volume":"11","author":"Vajda","year":"2004","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.seizure.2010.10.011_bib0040","first-page":"1210","article-title":"Effect of alpha-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats","volume":"29","author":"Grillo","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.seizure.2010.10.011_bib0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0009-9120(01)00217-X","article-title":"CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity","volume":"34","author":"Neuman","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1016\/j.seizure.2010.10.011_bib0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00044011-200323100-00005","article-title":"Bioavailability of a divalproex extended-release formulation versus the conventional divalproex formulation in adult patients receiving enzyme-inducing antiepileptic drugs","volume":"23","author":"Sommerville","year":"2003","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.seizure.2010.10.011_bib0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yebeh.2004.01.009","article-title":"Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy","volume":"5","author":"Pellock","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2010.10.011_bib0060","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.yebeh.2004.07.007","article-title":"Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials","volume":"5","author":"Smith","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2010.10.011_bib0065","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00228-006-0175-2","article-title":"Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics","volume":"62","author":"Herranz","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2010.10.011_bib0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0041-008X(85)90081-X","article-title":"Teratogenic valproic acid concentrations: infusion by implanted minipumps vs. conventional injection regimen in the mouse","volume":"80","author":"Nau","year":"1985","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.seizure.2010.10.011_bib0075","series-title":"Antiepileptic drug monitoring","article-title":"To what extent is drug entry into brain dependent on the way of administration. Some dipropylacetic acid experiments on cats","author":"Van Duijn","year":"1977"},{"key":"10.1016\/j.seizure.2010.10.011_bib0080","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1528-1157.1992.tb02356.x","article-title":"Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia). I. Antiepileptic actions","volume":"33","author":"Altrup","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.10.011_bib0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0006-8993(93)91534-Y","article-title":"Diffusion analysis of valproate and trans-2-en-valproate in agar and in cerebral cortex of the rat","volume":"631","author":"Lucke","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.seizure.2010.10.011_bib0090","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1528-1157.1995.tb01637.x","article-title":"Comparison of anticonvulsant efficacy of valproate during prolonged treatment with one and three daily doses or continuous (\u201ccontrolled release\u201d) administration in a model of generalized seizures in rats","volume":"36","author":"Loscher","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.10.011_bib0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0920-1211(02)00048-7","article-title":"Divalproex extended-release versus the original divalproex tablet: results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizures","volume":"50","author":"Thibault","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.10.011_bib0100","first-page":"37","article-title":"Genetic absence epilepsy in rats from Strasbourg \u2013 a review","volume":"35","author":"Marescaux","year":"1992","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.seizure.2010.10.011_bib0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0920-1211(94)00070-D","article-title":"Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats","volume":"20","author":"Leite","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.10.011_bib0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eplepsyres.2006.10.003","article-title":"Effect of antiepileptic drugs on spontaneous seizures in epileptic rats","volume":"73","author":"Nissinen","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.10.011_bib0115","article-title":"Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats","author":"van Vliet","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.10.011_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2004.03.009","article-title":"Kindling and status epilepticus models of epilepsy: rewiring the brain","volume":"73","author":"Morimoto","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.seizure.2010.10.011_bib0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1528-1157.1998.tb01268.x","article-title":"Antiepileptic drugs as a cause of worsening seizures","volume":"39","author":"Perucca","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.10.011_bib0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0920-1211(98)00017-5","article-title":"Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy","volume":"31","author":"Hellier","year":"1998","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.10.011_bib0135","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1528-1167.2008.01593.x","article-title":"Decreases in HCN mRNA expression in the hippocampus after kindling and status epilepticus in adult rats","volume":"49","author":"Powell","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.10.011_bib0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jneumeth.2009.01.024","article-title":"A novel system allowing long-term simultaneous video-electroencephalography recording, drug infusion and blood sampling in rats","volume":"179","author":"van Raay","year":"2009","journal-title":"J Neurosci Meth"},{"key":"10.1016\/j.seizure.2010.10.011_bib0145","first-page":"483","article-title":"Antiepileptic drug evaluation in a new animal model: spontaneous petit mal epilepsy in the rat","volume":"35","author":"Micheletti","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.seizure.2010.10.011_bib0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0031-9384(72)90249-1","article-title":"Another inexpensive headplug for the electrical recording and or stimulation of rats","volume":"9","author":"Molino","year":"1972","journal-title":"Physiol Behav"},{"key":"10.1016\/j.seizure.2010.10.011_bib0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/bdd.259","article-title":"Nonstationary disposition of valproic acid during prolonged intravenous infusion: contributions of unbound clearance and protein binding","volume":"22","author":"Arens","year":"2001","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.seizure.2010.10.011_bib0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.seizure.2010.10.011_bib0165","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0022-3565(25)32998-8","article-title":"Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse","volume":"220","author":"Nau","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.seizure.2010.10.011_bib0170","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)22759-8","article-title":"Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment","volume":"250","author":"Loscher","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.seizure.2010.10.011_bib0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1526-4610.2000.00002.x","article-title":"An analysis of the \u201ccarry-over effect\u201d following successful short-term treatment of transformed migraine with divalproex sodium","volume":"40","author":"Rothrock","year":"2000","journal-title":"Headache"},{"key":"10.1016\/j.seizure.2010.10.011_bib0180","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-3565(25)21843-2","article-title":"Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment","volume":"226","author":"Loscher","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.seizure.2010.10.011_bib0185","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1523\/JNEUROSCI.5320-05.2006","article-title":"Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami","volume":"26","author":"Brill","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2010.10.011_bib0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.seizure.2010.10.011_bib0195","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/brain\/awn079","article-title":"Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy","volume":"131","author":"Noe","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2010.10.011_bib0200","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1460-9568.2007.05348.x","article-title":"Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors","volume":"25","author":"Morris","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.seizure.2010.10.011_bib0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2004.11.022","article-title":"Neuropeptide Y suppresses absence seizures in a genetic rat model","volume":"1033","author":"Stroud","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.seizure.2010.10.011_bib0210","doi-asserted-by":"crossref","first-page":"27586","DOI":"10.1074\/jbc.M303740200","article-title":"Valproate induces replication-independent active DNA demethylation","volume":"278","author":"Detich","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.seizure.2010.10.011_bib0215","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/carcin\/bgl167","article-title":"Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes","volume":"28","author":"Milutinovic","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.seizure.2010.10.011_bib0220","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.2.5919.584","article-title":"Sodium valproate in treatment of epilepsy","volume":"2","author":"Jeavons","year":"1974","journal-title":"Brit Med J"},{"key":"10.1016\/j.seizure.2010.10.011_bib0225","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0404.2005.00524.x","article-title":"Progress in pharmaceutical development presentation with improved pharmacokinetics: a new formulation for valproate","volume":"182","author":"Genton","year":"2005","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.seizure.2010.10.011_bib0230","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eplepsyres.2009.09.015","article-title":"Once-daily dosing is appropriate for extended-release divalproex over a wide dose range, but not for enteric-coated, delayed-release divalproex: evidence via computer simulations and implications for epilepsy therapy","volume":"87","author":"Reed","year":"2009","journal-title":"Epilepsy Res"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131110002426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131110002426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:39:20Z","timestamp":1761010760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131110002426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1059131110002426"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2010.10.011","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2010.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}